Clinical Trials
4
Active:1
Completed:3
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine Lozenges
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- Fertin Pharma A/S
- Target Recruit Count
- 42
- Registration Number
- NCT03432273
- Locations
- 🇿🇦
Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein, South Africa
Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- Fertin Pharma A/S
- Target Recruit Count
- 42
- Registration Number
- NCT03432312
- Locations
- 🇿🇦
Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein, South Africa
Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum
- First Posted Date
- 2015-02-05
- Last Posted Date
- 2015-02-05
- Lead Sponsor
- Fertin Pharma A/S
- Target Recruit Count
- 15
- Registration Number
- NCT02356913
News
No news found